Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)
NCT01078220
·
clinicaltrials.gov ↗
COMPLETED
Status
189629
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Papillomavirus Infection
Sponsor
Merck Sharp & Dohme LLC
Collaborators
[object Object]